£790.00

It has never been this cheap. We have no record of a lower price.

£790 today · cheaper than every other day in the last 3 months

The 2025-2030 World Outlook for Non-Steroidal Anti-Inflammatory Drugs Segment - Topical Pain Relief

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 38 days · 38 data points (no recent data)

Historical
Generating forecast…
£790.00 £750.50 £766.30 £782.10 £797.90 £813.70 £829.50 22 August 2026 31 August 2026 09 September 2026 18 September 2026 28 September 2026
View at Amazon ↗

Price data last checked 53 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 38 days • 1 price levels

Days at Price
38 days 0 10 19 29 38 £790 Days at Price

Price Analysis

Most common price: £790 (38 days, 100.0%)

Price range: £790 - £790

Price levels: 1 different prices over 38 days

Description

This study covers the world outlook for non-steroidal anti-inflammatory drugs segment - topical pain relief across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of non-steroidal anti-inflammatory drugs segment - topical pain relief as including all commonly understood products falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include AdvaCare Pharma®, GlaxoSmithKline Plc (UK), Johnson & Johnson, Novartis, Pfizer Inc. (US), Reckitt Benckiser Group, Sanofi (EPA: SAN), Sun Pharmaceutical Industries, Teikoku Pharma, and Topical BioMedics, Inc.. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2024).

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
07 May 2024

Similar Products You Might Like

The 2027-2032 World Outlook for Pain Management Therapeutics
89% match

The 2027-2032 World Outlook for Pain Management Therapeutics

£890.00 22 Sep 2026
The 2026-2031 World Outlook for Pain-Relieving Lidocaine Patches
89% match

The 2026-2031 World Outlook for Pain-Relieving Lidocaine Patches

£885.00 22 Sep 2026
The 2026-2031 World Outlook for Anti-Smoking Drugs
88% match

The 2026-2031 World Outlook for Anti-Smoking Drugs

£885.00 22 Sep 2026
The 2026-2031 World Outlook for Nasal Sprays
88% match

The 2026-2031 World Outlook for Nasal Sprays

£885.00 22 Sep 2026
The 2026-2031 World Outlook for Drug Repurposing
88% match

The 2026-2031 World Outlook for Drug Repurposing

£885.00 28 Sep 2026
The 2025-2030 World Outlook for Alopecia Drugs
88% match

The 2025-2030 World Outlook for Alopecia Drugs

£790.00 28 Sep 2026
The 2027-2032 World Outlook for Peripheral Neuropathy Treatments
87% match

The 2027-2032 World Outlook for Peripheral Neuropathy Treatments

£890.00 22 Sep 2026
The 2027-2032 World Outlook for Inhalation and Nasal Spray Drugs
87% match

The 2027-2032 World Outlook for Inhalation and Nasal Spray Drugs

£890.00 22 Sep 2026
The 2023-2028 World Outlook for Pharma Contract Sales
87% match

The 2023-2028 World Outlook for Pharma Contract Sales

£795.00 15 Sep 2026
The 2025-2030 World Outlook for Nootropics
87% match

The 2025-2030 World Outlook for Nootropics

£790.00 28 Sep 2026
The 2025-2030 World Outlook for Non-Melanoma Skin Cancers
86% match

The 2025-2030 World Outlook for Non-Melanoma Skin Cancers

£790.00 28 Sep 2026
The 2023-2028 World Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs
86% match

The 2023-2028 World Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs

£795.00 15 Sep 2026
The 2025-2030 World Outlook for Immuno-Oncology
86% match

The 2025-2030 World Outlook for Immuno-Oncology

£790.00 28 Sep 2026
The 2025-2030 World Outlook for Nitrous Oxide Inhalation Anesthetics
86% match

The 2025-2030 World Outlook for Nitrous Oxide Inhalation Anesthetics

£790.00 28 Sep 2026
2027-2032 World Outlook for Pneumonia Therapeutic Drugs
86% match

2027-2032 World Outlook for Pneumonia Therapeutic Drugs

£890.00 28 Sep 2026
The 2025-2030 World Outlook for Alopecia Treatments
86% match

The 2025-2030 World Outlook for Alopecia Treatments

£790.00 28 Sep 2026
The 2023-2028 World Outlook for Therapeutic Cancer Vaccines
85% match

The 2023-2028 World Outlook for Therapeutic Cancer Vaccines

£795.00 13 Sep 2026
The 2018-2023 World Outlook for Analgesics
85% match

The 2018-2023 World Outlook for Analgesics

£815.00 28 Sep 2026
The 2025-2030 World Outlook for Sensitive Toothpaste
85% match

The 2025-2030 World Outlook for Sensitive Toothpaste

£790.00 28 Sep 2026
The 2025-2030 World Outlook for Cold, Cough, and Sore Throat Syrups and Drops
85% match

The 2025-2030 World Outlook for Cold, Cough, and Sore Throat Syrups and Drops

£790.00 28 Sep 2026
The 2023-2028 World Outlook for Irritable Bowel Syndrome Treatments
85% match

The 2023-2028 World Outlook for Irritable Bowel Syndrome Treatments

£795.00 15 Sep 2026
The 2023-2028 World Outlook for Endometrial Cancer Treatments
85% match

The 2023-2028 World Outlook for Endometrial Cancer Treatments

£795.00 15 Sep 2026
The 2025-2030 World Outlook for Nicotine Patches
85% match

The 2025-2030 World Outlook for Nicotine Patches

£790.00 28 Sep 2026
The 2026-2031 World Outlook for Somatostatin Analogs
85% match

The 2026-2031 World Outlook for Somatostatin Analogs

£885.00 28 Sep 2026